4005 — Sumitomo Chemical Co Balance Sheet
0.000.00%
- ¥555bn
- ¥2tn
- ¥3tn
- 33
- 89
- 63
- 69
Annual balance sheet for Sumitomo Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 373,732 | 389,420 | 337,081 | 248,787 | 254,853 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 652,616 | 720,422 | 603,161 | 620,022 | 593,836 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,584,471 | 1,812,642 | 1,762,884 | 1,675,882 | 1,583,134 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 793,500 | 823,022 | 829,355 | 796,526 | 759,266 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,990,254 | 4,308,151 | 4,165,503 | 3,934,818 | 3,439,784 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,090,692 | 1,173,491 | 1,278,367 | 1,443,487 | 1,038,747 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,971,024 | 3,090,050 | 2,994,311 | 2,969,065 | 2,538,994 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,019,230 | 1,218,101 | 1,171,192 | 965,753 | 900,790 |
Total Liabilities & Shareholders' Equity | 3,990,254 | 4,308,151 | 4,165,503 | 3,934,818 | 3,439,784 |
Total Common Shares Outstanding |